Vertex Pharmaceuticals | VRTX - PE Price to Earnings



Vertex Pharmaceuticals reported 27.81 in PE Price to Earnings for its fiscal quarter ending in June of 2025.


Pe Change Date
AbbVie 18.41 69.26 Jun/2025
Acadia Pharmaceuticals 16.19 4.11 Jun/2025
Agios Pharmaceuticals 2.88 0.36 Jun/2025
Amgen 12.51 28.7 Jun/2025
Arrowhead Research 436.79 383.28 Jun/2020
Biogen 12.41 0.17 Jun/2025
BioMarin Pharmaceutical 15.13 7.26 Jun/2025
Bristol-Myers Squibb 17.27 3.22 Jun/2025
Gilead Sciences 15.39 279.48 Jun/2025
Incyte 14.77 134.3 Jun/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
J&J 19.02 9.62 Jun/2025
Merck 8.58 4.74 Jun/2025
Moderna 27.22 14.51 Jun/2023
Neurocrine Biosciences 42.61 5.9 Jun/2025
Novartis 15.89 3.03 Jun/2025
Pfizer 9.12 8.86 Jun/2025
PTC Therapeutics 6.47 0.7 Jun/2025
Regeneron Pharmaceuticals 13.35 3.19 Jun/2025
Roche Holding 19.32 1.87 Jun/2024
Sanofi 16.47 6.85 Jun/2025
Sarepta Therapeutics 27.27 0 Jun/2025
United Therapeutics 11.45 0.02 Jun/2025
Vertex Pharmaceuticals 27.81 3.5 Jun/2025